Search Count: 99
 |
Crystal Structure Of Munia Coronavirus Hku13 Main Proteinase In Complex With A Broad-Spectrum Inhibitor
Organism: Munia coronavirus hku13-3514
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2026-08-19 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Munia coronavirus hku13-3514
Method: X-RAY DIFFRACTION
Release Date: 2026-08-19
Ligands: A1EYZ
 |
Crystal Structure Of Sars Coronavirus Main Proteinase In Complex With A Broad-Spectrum Inhibitor
Organism: Sars coronavirus urbani
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2026-08-19 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Sars coronavirus urbani
Method: X-RAY DIFFRACTION
Release Date: 2026-08-19
Ligands: A1EYZ
 |
Crystal Structure Of Norovirus 3C-Like Protease In Complex With A Broad-Spectrum Inhibitor
Organism: Norovirus (strain human/nov/united states/norwalk/1968/gi)
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2026-08-05 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Norovirus (strain human/nov/united states/norwalk/1968/gi)
Method: X-RAY DIFFRACTION
Release Date: 2026-08-05
Ligands: A1EYZ
 |
Crystal Structure Of Enterovirus A71 3C Protease In Complex With A Broad-Spectrum Inhibitor
Organism: Human enterovirus 71 (strain brcr)
Method: X-RAY DIFFRACTION Resolution:1.59 Å Release Date: 2026-08-05 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Human enterovirus 71 (strain brcr)
Method: X-RAY DIFFRACTION
Release Date: 2026-08-05
Ligands: A1EYZ
 |
Crystal Structure Of Human Rhinovirus A2 3C Protease In Complex With A Broad-Spectrum Inhibitor
Organism: Rhinovirus a2
Method: X-RAY DIFFRACTION Resolution:1.76 Å Release Date: 2026-08-05 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Rhinovirus a2
Method: X-RAY DIFFRACTION
Release Date: 2026-08-05
Ligands: A1EYZ
 |
Crystal Structure Of Coxsackievirus B5 3C Protease In Complex With A Broad-Spectrum Inhibitor
Organism: Coxsackievirus b5
Method: X-RAY DIFFRACTION Resolution:1.95 Å Release Date: 2026-08-05 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Coxsackievirus b5
Method: X-RAY DIFFRACTION
Release Date: 2026-08-05
Ligands: A1EYZ
 |
Crystal Structure Of Sars-Cov-2 Main Protease In Complex With A Broad-Spectrum Inhibitor
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION Resolution:2.05 Å Release Date: 2026-08-05 Classification: VIRAL PROTEIN Ligands: A1EYZ |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: X-RAY DIFFRACTION
Release Date: 2026-08-05
Ligands: A1EYZ
 |
Glun1B-Glun2B Atd In Complex With Radiprodil
Organism: Xenopus laevis, Rattus norvegicus
Method: X-RAY DIFFRACTION Resolution:2.74 Å Release Date: 2026-07-22 Classification: MEMBRANE PROTEIN Ligands: NAG, A1CNW, NA, CL |
Organism: Xenopus laevis, Rattus norvegicus
Method: X-RAY DIFFRACTION
Release Date: 2026-07-22
Ligands: NAG, A1CNW, NA, CL
 |
Crystal Structure Of Rv0866 From Mycobacterium Tuberculosis
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2026-02-11 Classification: TRANSFERASE Ligands: MPD |
Organism: Mycobacterium tuberculosis h37rv
Method: X-RAY DIFFRACTION
Release Date: 2026-02-11
Ligands: MPD
 |
Gii.4 Human Norovirus 3Cl Protease Bound To Compound 27
Organism: Norovirus, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-12-31 Classification: VIRAL PROTEIN/INHIBITOR |
Organism: Norovirus, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-12-31
 |
Sars-Cov2 Mpro Bound To Compound 1
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.74 Å Release Date: 2025-12-31 Classification: VIRAL PROTEIN/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-12-31
 |
Sars-Cov2 Main Protease Bound To Compound 26
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.54 Å Release Date: 2025-12-31 Classification: VIRAL PROTEIN/INHIBITOR Ligands: SO4, NA |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-12-31
Ligands: SO4, NA
 |
Crystal Structure Of The Moae-Like Domain Within Rv3323C From Mycobacterium Tuberculosis
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION Resolution:2.40 Å Release Date: 2025-08-27 Classification: TRANSFERASE Ligands: MES, GOL |
Organism: Mycobacterium tuberculosis (strain atcc 25618 / h37rv)
Method: X-RAY DIFFRACTION
Release Date: 2025-08-27
Ligands: MES, GOL
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.37 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBOTOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.89 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:1.47 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Discovery Of An Orally Bioavailable Reversible Covalent Sars-Cov-2 Mpro Inhibitor With Pan-Coronavirus Activity
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION Resolution:2.20 Å Release Date: 2025-08-20 Classification: HYDROLASE/INHIBITOR Ligands: A1L7M |
Organism: Severe acute respiratory syndrome coronavirus 2, Synthetic construct
Method: X-RAY DIFFRACTION
Release Date: 2025-08-20
Ligands: A1L7M
 |
Cryo-Em Structure Of The Rubisco From Thermophilic Purple Bacterial Rubisco
Organism: Thermochromatium tepidum atcc 43061
Method: ELECTRON MICROSCOPY Release Date: 2025-03-05 Classification: PLANT PROTEIN |
Organism: Thermochromatium tepidum atcc 43061
Method: ELECTRON MICROSCOPY
Release Date: 2025-03-05
 |
Crystal Structure Of Co Dehydrogenase Mutant With Increased Affinity For Electron Mediators In High Peg Concentration
Organism: Carboxydothermus hydrogenoformans z-2901
Method: X-RAY DIFFRACTION Resolution:2.11 Å Release Date: 2024-04-17 Classification: ELECTRON TRANSPORT Ligands: SF4, FES, XCC, FE, 1PE |
Organism: Carboxydothermus hydrogenoformans z-2901
Method: X-RAY DIFFRACTION
Release Date: 2024-04-17
Ligands: SF4, FES, XCC, FE, 1PE